Applications of Positron Emission Tomography in the Newborn Nursery

Seminars in Perinatology

Volumn 34, Issue 1, 2010, Pages 39-45

  Kannan, Sujatha ^a   Chugani, Harry T ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cerebral palsy; hypoxic ischemic encephalopathy; neonatal seizures; perinatal brain injury; PET imaging

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; FLUMAZENIL C 11; FLUORODEOXYGLUCOSE; N METHYLTRYPTOPHAN; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; TRACER;

BRAIN DEVELOPMENT; BRAIN DISEASE; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CEREBRAL PALSY; DIAGNOSTIC VALUE; DRUG RECEPTOR BINDING; EARLY DIAGNOSIS; ENCEPHALITIS; HUMAN; NEUROLOGIC DISEASE; NEWBORN; NON INVASIVE PROCEDURE; NONHUMAN; PEDIATRICS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEIZURE;

BRAIN; CEREBRAL PALSY; GLUCOSE; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; POSITRON-EMISSION TOMOGRAPHY; SEIZURES;

EID: 74549116669     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2009.10.004     Document Type: Review

References (61)

1. Chugani H.T., and Phelps M.E. Maturational changes in cerebral function in infants determined by 18FDG positron emission tomography. Science 231 (1986) 840-843
2. Chugani H.T., Phelps M.E., and Mazziotta J.C. Positron emission tomography study of human brain functional development. Ann Neurol 22 (1987) 487-497
3. Chugani H.T. A critical period of brain development: studies of cerebral glucose utilization with PET. Prev Med 27 (1998) 184-188
4. Kinnala A., Suhonen-Polvi H., Aärimaa T., et al. Cerebral metabolic rate for glucose during the first six months of life: an FDG positron emission tomography study. Arch Dis Child Fetal Neonatal Ed 74 (1996) F153-F157
5. Chugani H.T., Behen M.E., Muzik O., et al. Local brain functional activity following early deprivation: a study of postinstitutionalized Romanian orphans. Neuroimage 14 (2001) 1290-1301
6. Berg A.T., Levy S.R., Novotny E.J., et al. Predictors of intractable epilepsy in childhood: a case-control study. Epilepsia 37 (1996) 24-30
7. Sun Y., Vestergaard M., Christensen J., et al. Prenatal exposure to maternal infections and epilepsy in childhood: a population-based cohort study. Pediatrics 121 (2008) e1100-e1107
8. Whitehead E., Dodds L., Joseph K.S., et al. Relation of pregnancy and neonatal factors to subsequent development of childhood epilepsy: a population-based cohort study. Pediatrics 117 (2006) 1298-1306
9. Thibeault-Eybalin M.P., Lortie A., and Carmant L. Neonatal seizures: Do they damage the brain?. Pediatr Neurol 40 (2009) 175-180
10. Juhász C., and Chugani H.T. Imaging the epileptic brain with positron emission tomography (Review). Neuroimag Clin N Am 13 (2003) 705-716 viii
11. Chugani H.T. The role of PET in childhood epilepsy. J Child Neurol 9 suppl 1 (1994) S82-S88
12. Da Silva E.A., Chugani D.C., Muzik O., et al. Identification of frontal lobe epileptic foci in children using positron emission tomography. Epilepsia 38 (1997) 1198-1208
13. Juhász C., Chugani D.C., Muzik O., et al. Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome. Neurology 26 (2001) 1650-1658
14. Savic I., Thorell J.O., and Roland P. [11C]Flumazenil positron emission tomography visualizes frontal epileptogenic regions. Epilepsia 36 (1996) 1225-1232
15. Muzik O., da Silva E.A., Juhasz C., et al. Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. Neurology 11 (2000) 171-179
16. Juhász C., Chugani D.C., and Muzik O. Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology 25 (2003) 960-968
17. Juhász C., Chugani D.C., Muzik O., et al. Relationship between EEG and positron emission tomography abnormalities in clinical epilepsy. J Clin Neurophysiol 17 (2000) 29-42
18. Asano E., Chugani D.C., Juhász C., et al. Surgical treatment of West syndrome. Brain Dev 23 (2001) 668-676
19. Koman L.A., Smith B.P., and Shilt J.S. Cerebral palsy. Lancet 363 (2004) 1619-1631
20. Bejar R.F., Vaucher Y.E., Benirschke K., et al. Postnatal white matter necrosis in preterm infants. J Perinatol 12 (1992) 3-8
21. Cioni G., Di Paco M.C., Bertuccelli B., et al. MRI findings and sensorimotor development in infants with bilateral spastic cerebral palsy. Brain Dev 19 (1997) 245-253
22. Hashimoto K., Hasegawa H., Kida Y., et al. Correlation between neuroimaging and neurological outcome in periventricular leukomalacia: diagnostic criteria. Pediatr Int 43 (2001) 240-245
23. Kułak W., Sobaniec W., Kubas B., et al. Spastic cerebral palsy: clinical magnetic resonance imaging correlation of 129 children. J Child Neurol 22 (2007) 8-14
24. Lee Z.I., Byun W.M., Jang S.H., et al. Diffusion tensor magnetic resonance imaging of microstructural abnormalities in children with brain injury. Am J Phys Med Rehabil 82 (2003) 556-559
25. Son S.M., Ahn Y.H., Sakong J., et al. Diffusion tensor imaging demonstrates focal lesions of the corticospinal tract in hemiparetic patients with cerebral palsy. Neurosci Lett 420 (2007) 34-38
26. Korzeniewski S.J., Birbeck G., DeLano M.C., et al. A systematic review of neuroimaging for cerebral palsy. J Child Neurol 23 (2008) 216-227
27. Volpe J.J., Herscovitch P., Perlman J.M., et al. Positron emission tomography in the newborn: extensive impairment of regional cerebral blood flow with intraventricular hemorrhage and hemorrhagic intracerebral involvement. Pediatrics 72 (1983) 589-601
28. Volpe J.J., Herscovitch P., Perlman J.M., et al. Positron emission tomography in the asphyxiated term newborn: parasagittal impairment of cerebral blood flow. Ann Neurol 17 (1985) 287-296
29. Altman D.I., and Volpe J.J. Positron emission tomography in newborn infants (Review). Clin Perinatol 18 (1991) 549-562
30. Kerrigan J.F., Chugani H.T., and Phelps M.E. Regional cerebral glucose metabolism in clinical subtypes of cerebral palsy. Pediatr Neurol 7 (1991) 415-425
31. Inder T.E., Huppi P.S., Warfield S., et al. Periventricular white matter injury in the premature infant is followed by reduced cerebral cortical gray matter volume at term. Ann Neurol 46 (1999) 755-760
32. Batista C.E., Chugani H.T., Juhász C., et al. Transient hypermetabolism of the basal ganglia following perinatal hypoxia. Pediatr Neurol 36 (2007) 330-333
33. Hoon Jr. A.H., Lawrie Jr. W.T., Melhem E.R., et al. Diffusion tensor imaging of periventricular leukomalacia shows affected sensory cortex white matter pathways. Neurology 10 (2002) 752-756
34. Lee J.D., Park H.J., Park E.S., et al. Assessment of regional GABA(A) receptor binding using 18F-fluoroflumazenil positron emission tomography in spastic type cerebral palsy. Neuroimage 34 (2007) 19-25
35. Chugani D.C., Muzik O., Juhász C., et al. Postnatal maturation of human GABAA receptors measured with positron emission tomography. Ann Neurol 49 (2001) 618-626
36. Bell M.J., and Hallenbeck J.M. Effects of intrauterine inflammation on developing rat brain. J Neurosci Res 70 (2002) 570-579
37. Cai Z., Pan Z.L., Pang Y., et al. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr Res 47 (2000) 64-72
38. Saadani-Makki F., Kannan S., Lu X., et al. Intrauterine administration of endotoxin leads to motor deficits in a rabbit model: a link between prenatal infection and cerebral palsy. Am J Obstet Gynecol 199 (2008) 651-657
39. Li J., Baud O., Vartanian T., et al. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci USA 102 (2005) 9936-9941
40. Block M.L., Zecca L., and Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8 (2007) 57-69
41. Vilhardt F. Microglia: phagocyte and glia cell. Int J Biochem Cell Biol 37 (2005) 17-21
42. Nimmerjahn A., Kirchhoff F., and Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308 (2005) 1314-1318
43. Billiards S.S., Haynes R.L., Folkerth R.D., et al. Development of microglia in the cerebral white matter of the human fetus and infant. J Comp Neurol 497 (2006) 199-208
44. Lawson L.J., Perry V.H., Dri P., et al. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39 (1990) 151-170
45. Haynes R.L., Folkerth R.D., Keefe R.J., et al. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol 62 (2003) 441-450
46. Espey M.G., Chernyshev O.N., Reinhard Jr. J.F., et al. Activated human microglia produce the excitotoxin quinolinic acid. Neuroreport 8 (1997) 431-434
47. Dommergues M.A., Plaisant F., Verney C., et al. Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection. Neuroscience 121 (2003) 619-628
48. Fern R., and Moller T. Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J Neurosci 20 (2000) 34-42
49. Salter M.G., and Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 438 (2005) 1167-1171
50. Dammann O., and Leviton A. Infection remote from the brain, neonatal white matter damage, and cerebral palsy in the preterm infant. Semin Pediatr Neurol 5 (1998) 190-201
51. Nelson K.B., Dambrosia J.M., Grether J.K., et al. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 44 (1998) 665-675
52. Yoon B.H., Romero R., Park J.S., et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 182 (2000) 675-681
53. Hailer N.P., Vogt C., Korf H.W., et al. Interleukin-1beta exacerbates and interleukin-1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic hippocampal slice cultures. Eur J Neurosci 21 (2005) 2347-2360
54. Lehnardt S., Lachance C., Patrizi S., et al. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci 22 (2002) 2478-2486
55. Garnier M., Boujrad N., Ogwuegbu S.O., et al. The polypeptide diazepam-binding inhibitor and a higher affinity mitochondrial peripheral-type benzodiazepine receptor sustain constitutive steroidogenesis in the R2C Leydig tumor cell line. J Biol Chem 269 (1994) 22105-22112
56. Banati R.B. Visualising microglial activation in vivo. Glia 40 (2002) 206-217
57. Gerhard A., Banati R.B., Goerres G.B., et al. [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology 61 (2003) 686-689
58. Papadopoulos V., Baraldi M., Guilarte T.R., et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27 (2006) 402-409
59. Gerhard A., Pavese N., Hotton G., et al. In vivo imaging of microglial activation with [11C] (R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol Dis 21 (2006) 404-412
60. Kannan S., Saadani-Makki F., Muzik O., et al. Microglial activation in perinatal rabbit brain induced by intrauterine inflammation: detection with 11C-(R)-PK11195 and small-animal PET. J Nucl Med 48 (2007) 946-954
61. Brenner D.J., and Hall E.J. Computed tomography-an increasing source of radiation exposure. N Engl J Med 357 (2007) 2277-2284